Bio-Techne (TECH) Interest Expenses (2009 - 2026)
Bio-Techne (TECH) posted quarterly Interest Expenses of $26.9 million for Q1 2026, down 41.56% year-over-year from $46.0 million in Q1 2025, and little changed quarter-over-quarter from $26.9 million in Q4 2025.
Bio-Techne (TECH) Interest Expenses (2009 - 2026) Analysis & Trends
Bio-Techne's Interest Expenses history runs 18 years deep, the most recent figure standing at $26.9 million for Q1 2026.
- In Q1 2026, Interest Expenses fell 41.56% year-over-year to $26.9 million; the TTM figure through Mar 2026 stood at $26.9 million (down 41.56% YoY), while the FY2025 annual figure was $155.0 million, down 79.26% from the prior year.
- Interest Expenses for Q1 2026 stood at $26.9 million, roughly flat from $26.9 million in the prior quarter.
- The five-year high for Interest Expenses was $61.9 million in Q1 2022, with the low at $2.2 million in Q2 2025.
- The 5-year median for Interest Expenses is $46.0 million (2025), against an average of $38.0 million.
- The sharpest annual moves came in 2022 and 2025: Interest Expenses soared 460.15% in 2022, then tumbled 51.62% in 2025.
- Bio-Techne's Interest Expenses stood at $57.3 million in 2022, then climbed by 0.71% to $57.7 million in 2023, then decreased by 20.48% to $45.9 million in 2024, then slumped by 41.36% to $26.9 million in 2025, then retreated by 0.04% to $26.9 million in 2026.
- Business Quant data shows TECH's Interest Expenses at $26.9 million in Q1 2026, $26.9 million in Q4 2025, and $26.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 439.40 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 52.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.70 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 39.74 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 335,572.77 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 218.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 82.05 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Bio-Techne | 11.33 Bn | 11.12 Bn | 208.29 Mn | 26.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.91 Mn |
| Mar 31, 2026 | 26.91 Mn |
| Dec 31, 2025 | 26.92 Mn |
| Dec 31, 2025 | 26.92 Mn |
| Sep 30, 2025 | 26.91 Mn |
| Sep 30, 2025 | 26.91 Mn |
| Jun 30, 2025 | 2.18 Mn |
| Jun 30, 2025 | 2.18 Mn |
| Mar 31, 2025 | 46.05 Mn |
| Mar 31, 2025 | 46.05 Mn |
| Dec 31, 2024 | 45.91 Mn |
| Dec 31, 2024 | 45.91 Mn |
| Sep 30, 2024 | 46.20 Mn |
| Sep 30, 2024 | 46.20 Mn |
| Jun 30, 2024 | 4.50 Mn |
| Jun 30, 2024 | 4.50 Mn |
| Mar 31, 2024 | 57.38 Mn |
| Mar 31, 2024 | 57.38 Mn |
| Dec 31, 2023 | 57.73 Mn |
| Dec 31, 2023 | 57.73 Mn |